Literature DB >> 22728038

Exaggerated inflammatory responses mediated by Burkholderia cenocepacia in human macrophages derived from Cystic fibrosis patients.

Benjamin T Kopp1, Basant A Abdulrahman, Arwa A Khweek, Surender B Kumar, Anwari Akhter, Richard Montione, Mia F Tazi, Kyle Caution, Karen McCoy, Amal O Amer.   

Abstract

Cystic fibrosis (CF) is accompanied with heightened inflammation worsened by drug resistant Burkholderia cenocepacia. Human CF macrophage responses to B. cenocepacia are poorly characterized and variable in the literature. Therefore, we examined human macrophage responses to the epidemic B. cenocepacia J2315 strain in order to identify novel anti-inflammatory targets. Peripheral blood monocyte derived macrophages were obtained from 23 CF and 27 non-CF donors. Macrophages were infected with B. cenocepacia J2315 and analyzed for cytokines, cytotoxicity, and microscopy. CF macrophages demonstrated significant increases in IL-1β, IL-10, MCP-1, and IFN-γ production in comparison to non-CF controls. CF patients on prednisone exhibited globally diminished cytokines compared to controls and other CF patients. CF macrophages also displayed increased bacterial burden and cell death. In conclusion, CF macrophages demonstrate exaggerated IL-1β, IL-10, MCP-1, and IFN-γ production and cell death during B. cenocepacia infection. Treatment with corticosteroids acutely suppressed cytokine responses.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22728038      PMCID: PMC3408781          DOI: 10.1016/j.bbrc.2012.06.066

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  28 in total

1.  Lower airway inflammation in infants with cystic fibrosis detected by newborn screening.

Authors:  David S Armstrong; Sarah M Hook; Kris M Jamsen; Gillian M Nixon; Rosemary Carzino; John B Carlin; Colin F Robertson; Keith Grimwood
Journal:  Pediatr Pulmonol       Date:  2005-12

2.  Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis.

Authors:  J R Govan; P H Brown; J Maddison; C J Doherty; J W Nelson; M Dodd; A P Greening; A K Webb
Journal:  Lancet       Date:  1993-07-03       Impact factor: 79.321

3.  Survival following Burkholderia cepacia sepsis in a patient with cystic fibrosis treated with corticosteroids.

Authors:  M Kazachkov; J Lager; J LiPuma; P M Barker
Journal:  Pediatr Pulmonol       Date:  2001-10

4.  Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis.

Authors:  A M Jones; M E Dodd; J R W Govan; V Barcus; C J Doherty; J Morris; A K Webb
Journal:  Thorax       Date:  2004-11       Impact factor: 9.139

5.  Pseudomonas cepacia infection in cystic fibrosis: an emerging problem.

Authors:  A Isles; I Maclusky; M Corey; R Gold; C Prober; P Fleming; H Levison
Journal:  J Pediatr       Date:  1984-02       Impact factor: 4.406

6.  Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine interleukin-10, which is downregulated in cystic fibrosis.

Authors:  T L Bonfield; M W Konstan; P Burfeind; J R Panuska; J B Hilliard; M Berger
Journal:  Am J Respir Cell Mol Biol       Date:  1995-09       Impact factor: 6.914

7.  Inflammatory cytokines in cystic fibrosis lungs.

Authors:  T L Bonfield; J R Panuska; M W Konstan; K A Hilliard; J B Hilliard; H Ghnaim; M Berger
Journal:  Am J Respir Crit Care Med       Date:  1995-12       Impact factor: 21.405

8.  Up-regulation of interleukin-10 mRNA expression in peripheral leukocytes predicts poor outcome and diminished human leukocyte antigen-DR expression on monocytes in septic patients.

Authors:  Ryuzo Abe; Hiroyuki Hirasawa; Shigeto Oda; Tomohito Sadahiro; Masataka Nakamura; Eizo Watanabe; Taka-Aki Nakada; Masahiko Hatano; Takeshi Tokuhisa
Journal:  J Surg Res       Date:  2007-08-20       Impact factor: 2.192

9.  Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis.

Authors:  J J LiPuma; S E Dasen; D W Nielson; R C Stern; T L Stull
Journal:  Lancet       Date:  1990-11-03       Impact factor: 79.321

10.  Burkholderia cenocepacia lipopolysaccharide, lipid A, and proinflammatory activity.

Authors:  Anthony De Soyza; Charles D Ellis; C M Anjam Khan; Paul A Corris; Raquel Demarco de Hormaeche
Journal:  Am J Respir Crit Care Med       Date:  2004-03-24       Impact factor: 21.405

View more
  29 in total

Review 1.  The cooperation between the autophagy machinery and the inflammasome to implement an appropriate innate immune response: do they regulate each other?

Authors:  Dalia H A Abdelaziz; Hany Khalil; Estelle Cormet-Boyaka; Amal O Amer
Journal:  Immunol Rev       Date:  2015-05       Impact factor: 12.988

2.  Down-regulation of IL-8 by high-dose vitamin D is specific to hyperinflammatory macrophages and involves mechanisms beyond up-regulation of DUSP1.

Authors:  N Dauletbaev; K Herscovitch; M Das; H Chen; J Bernier; E Matouk; J Bérubé; S Rousseau; L C Lands
Journal:  Br J Pharmacol       Date:  2015-10       Impact factor: 8.739

3.  Immune Recognition of the Epidemic Cystic Fibrosis Pathogen Burkholderia dolosa.

Authors:  Damien Roux; Molly Weatherholt; Bradley Clark; Mihaela Gadjeva; Diane Renaud; David Scott; David Skurnik; Gregory P Priebe; Gerald Pier; Craig Gerard; Deborah R Yoder-Himes
Journal:  Infect Immun       Date:  2017-05-23       Impact factor: 3.441

4.  Human Cystic Fibrosis Macrophages Have Defective Calcium-Dependent Protein Kinase C Activation of the NADPH Oxidase, an Effect Augmented by Burkholderia cenocepacia.

Authors:  Kaivon Assani; Chandra L Shrestha; Frank Robledo-Avila; Murugesan V Rajaram; Santiago Partida-Sanchez; Larry S Schlesinger; Benjamin T Kopp
Journal:  J Immunol       Date:  2017-01-16       Impact factor: 5.422

5.  Whole-blood transcriptomic responses to lumacaftor/ivacaftor therapy in cystic fibrosis.

Authors:  Benjamin T Kopp; James Fitch; Lisa Jaramillo; Chandra L Shrestha; Frank Robledo-Avila; Shuzhong Zhang; Sabrina Palacios; Fred Woodley; Don Hayes; Santiago Partida-Sanchez; Octavio Ramilo; Peter White; Asuncion Mejias
Journal:  J Cyst Fibros       Date:  2019-08-29       Impact factor: 5.482

6.  X-Box-Binding Protein 1 and Innate Immune Responses of Human Cystic Fibrosis Alveolar Macrophages.

Authors:  Bob A Lubamba; Lisa C Jones; Wanda K O'Neal; Richard C Boucher; Carla M P Ribeiro
Journal:  Am J Respir Crit Care Med       Date:  2015-12-15       Impact factor: 21.405

Review 7.  Cystic Fibrosis Lung Immunity: The Role of the Macrophage.

Authors:  Emanuela M Bruscia; Tracey L Bonfield
Journal:  J Innate Immun       Date:  2016-06-24       Impact factor: 7.349

8.  Elevated Mirc1/Mir17-92 cluster expression negatively regulates autophagy and CFTR (cystic fibrosis transmembrane conductance regulator) function in CF macrophages.

Authors:  Mia F Tazi; Duaa A Dakhlallah; Kyle Caution; Madelyn M Gerber; Sheng-Wei Chang; Hany Khalil; Benjamin T Kopp; Amr E Ahmed; Kathrin Krause; Ian Davis; Clay Marsh; Amy E Lovett-Racke; Larry S Schlesinger; Estelle Cormet-Boyaka; Amal O Amer
Journal:  Autophagy       Date:  2016-11       Impact factor: 16.016

9.  Defective immunometabolism pathways in cystic fibrosis macrophages.

Authors:  Kaitlin Hamilton; Kathrin Krause; Asmaa Badr; Kylene Daily; Shady Estfanous; Mostafa Eltobgy; Arwa Abu Khweek; Midhun N K Anne; Cierra Carafice; Daniel Baetzhold; Jeffrey R Tonniges; Xiaoli Zhang; Mikhail A Gavrilin; Narasimham L Parinandi; Amal O Amer
Journal:  J Cyst Fibros       Date:  2020-11-15       Impact factor: 5.482

Review 10.  Macrophage-mediated inflammation and disease: a focus on the lung.

Authors:  Emily Gwyer Findlay; Tracy Hussell
Journal:  Mediators Inflamm       Date:  2012-12-12       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.